The effect of electronegativity and angiotensin-converting enzyme inhibition on the kinin-forming capacity of polyacrylonitrile dialysis membranes

Biomaterials

Volumn 29, Issue 9, 2008, Pages 1139-1146

  Désormeaux, Anik ^a   Moreau, Marie Eve ^a   Lepage, Yves ^a   Chanard, Jacques ^b   Adam, Albert ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

Biocompatibility; Electroactive polymer; Haemodialysis membrane; Hypersensitivity

Indexed keywords

BIOCOMPATIBILITY; ELECTRONEGATIVITY; ENZYME INHIBITION;

EXPERIMENTAL MODELS; KININ-FORMING;

POLYACRYLONITRILES;

BIOMATERIAL; BLOOD CLOTTING FACTOR 12; BRADYKININ[1-8]; DIPEPTIDYL CARBOXYPEPTIDASE; KININ; POLYACRYLONITRILE; POLYETHYLENEIMINE;

ARTICLE; DIALYSIS MEMBRANE; ENZYME INHIBITION; EX VIVO STUDY; HEMODIALYSIS; HUMAN; IMMUNOBLOTTING; MOLECULAR WEIGHT; PRIORITY JOURNAL; ZETA POTENTIAL;

ACRYLIC RESINS; ACRYLONITRILE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BRADYKININ; ELECTROCHEMISTRY; FEMALE; HUMANS; KININS; MALE; MATERIALS TESTING; MEMBRANE POTENTIALS; MEMBRANES, ARTIFICIAL; RENAL DIALYSIS;

EID: 38349019673     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2007.11.019     Document Type: Article

References (21)

1. Schaefer R.M., Schaefer L., and Horl W.H. Anaphylactoid reactions during hemodialysis. Clin Nephrol 42 Suppl. 1 (1994) S44-S47
2. Granowitz E.V., Santos A.A., Poutsiaka D.D., Cannon J.G., Wilmore D.W., Wolff S.M., et al. Production of interleukin-1-receptor antagonist during experimental endotoxaemia. Lancet 338 (1991) 1423-1424
3. Bommer J., Wilhelms O.H., Barth H.P., Schindele H., and Ritz E. Anaphylactoid reactions in dialysis patients: role of ethylene-oxide. Lancet 2 (1985) 1382-1385
4. Chanard J., Lavaud S., Lavaud F., Toupance O., and Kochman S. IgE antibodies to isocyanates in hemodialyzed patients. ASAIO Trans 33 (1987) 551-553
5. Fink E., Lemke H.D., Verresen L., and Shimamoto K. Kinin generation by hemodialysis membranes as a possible cause of anaphylactoid reactions. Braz J Med Biol Res 27 (1994) 1975-1983
6. Schulman G., Hakim R., Arias R., Silverberg M., Kaplan A.P., and Arbeit L. Bradykinin generation by dialysis membranes: possible role in anaphylactic reaction. J Am Soc Nephrol 3 (1993) 1563-1569
7. Verresen L., Fink E., Lemke H.D., and Vanrenterghem Y. Bradykinin is a mediator of anaphylactoid reactions during hemodialysis with AN69 membranes. Kidney Int 45 (1994) 1497-1503
8. Cyr M., Lepage Y., Blais Jr. C., Gervais N., Cugno M., Rouleau J.L., et al. Bradykinin and des-Arg(9)-bradykinin metabolic pathways and kinetics of activation of human plasma. Am J Physiol Heart Circ Physiol 281 (2001) H275-H283
9. Duan Q.L., Nikpoor B., Dube M.P., Molinaro G., Meijer I.A., Dion P., et al. A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors. Am J Hum Genet 77 (2005) 617-626
10. Molinaro G., Duan Q.L., Chagnon M., Moreau M.E., Simon P., Clavel P., et al. Kinin-dependent hypersensitivity reactions in hemodialysis: metabolic and genetic factors. Kidney Int 70 (2006) 1823-1831
11. Adam A., Albert A., Calay G., Closset J., Damas J., and Franchimont P. Human kininogens of low and high molecular mass: quantification by radioimmunoassay and determination of reference values. Clin Chem 31 (1985) 423-426
12. Molinaro G., Carmona A.K., Juliano M.A., Juliano L., Malitskaya E., Yessine M.A., et al. Human recombinant membrane-bound aminopeptidase P: production of a soluble form and characterization using novel, internally quenched fluorescent substrates. Biochem J 385 (2005) 389-397
13. Mulvihill J., Cazenave J.P., Mazzucotelli J.P., Crost T., Collier C., Renaux J.L., et al. Minimodule dialyser for quantitative ex vivo evaluation of membrane haemocompatibility in humans: comparison of acrylonitrile copolymer, cuprophan and polysulphone hollow fibres. Biomaterials 13 (1992) 527-536
14. Moreau M.E., Thibault L., Desormeaux A., Chagnon M., Lemieux R., Robillard P., et al. Generation of kinins during preparation and storage of whole blood-derived platelet concentrates. Transfusion 47 (2007) 410-420
15. Decarie A., Drapeau G., Closset J., Couture R., and Adam A. Development of digoxigenin-labeled peptide: application to chemiluminoenzyme immunoassay of bradykinin in inflamed tissues. Peptides 15 (1994) 511-518
16. Raymond P., Drapeau G., Raut R., Audet R., Marceau F., Ong H., et al. Quantification of des-Arg9-bradykinin using a chemiluminescence enzyme immunoassay: application to its kinetic profile during plasma activation. J Immunol Methods 180 (1995) 247-257
17. Chanard J., Lavaud S., Randoux C., and Rieu P. New insights in dialysis membrane biocompatibility: relevance of adsorption properties and heparin binding. Nephrol Dial Transplant 18 (2003) 252-257
18. Thomas M., Valette P., Mausset A.L., and Dejardin P. High molecular weight kininogen adsorption on hemodialysis membranes: influence of pH and relationship with contact phase activation of blood plasma. Influence of pre-treatment with poly(ethyleneimine). Int J Artif Organs 23 (2000) 20-26
19. Decarie A., Adam A., and Couture R. Effects of captopril and Icatibant on bradykinin (BK) and des [Arg9] BK in carrageenan-induced edema. Peptides 17 (1996) 1009-1015
20. Adam A. Ecogenetic aspects of acute side effects caused by angiotensin converting enzyme inhibitors. Bull Mem Acad R Med Belg 159 (2004) 307-313 [discussion: 314-5]
21. Sabourin T., Guay K., Houle S., Bouthillier J., Bachvarov D.R., Adam A., et al. Absence of ligand-induced regulation of kinin receptor expression in the rabbit. Br J Pharmacol 133 (2001) 1154-1162